Silver Book Fact

Hip fracture prevention in at-risk, postmenopausal women saves $333 million annually.

Lasker Foundation. Exceptional Returns: The economic value of America’s investment in medical research. 2000; https://www.medscape.com/viewarticle/447944

Reference

Title
Exceptional Returns: The economic value of America’s investment in medical research
Publisher
Funding First
Publication Date
2000
Authors
Lasker Foundation
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Preventing Secondary Osteoporotic Fractures Yields Big Medicare Savings
     
  • An increase in bone mineral density (BMD) testing and osteoporosis treatment was associated with a decrease in hip fracture incidence.  
  • Treatment with zoledronic acid over a 3-year period reduced risk of vertebral fracture by around 70% and risk of hip fracture by 41%, and increased bone mineral density (BMD) by…  
  • Risedronate, a bisphosphonate, has been shown to increase vertebral bone mineral density (BMD) by around 5% and hip BMD by 2% to 3% in postmenopausal women with osteoporosis.  
  • A meta-analysis of clinical trials found that Vitamin D supplements reduced the risk of vertebral fractures by around 37%.